Jill M. Broadfoot
2006 - Vical
In 2006, Jill M. Broadfoot earned a total compensation of $578.8K as Senior Vice President, Chief Financial Officer and Secretary at Vical.
Compensation breakdown
| Bonus | $60,000 |
|---|---|
| Option Awards | $171,534 |
| Salary | $273,075 |
| Stock Awards | $67,000 |
| Other | $7,147 |
| Total | $578,756 |
Broadfoot received $273.1K in salary, accounting for 47% of the total pay in 2006.
Broadfoot also received $60K in bonus, $171.5K in option awards, $67K in stock awards and $7.1K in other compensation.
Rankings
In 2006, Jill M. Broadfoot's compensation ranked 4,322nd out of 7,022 executives tracked by ExecPay. In other words, Broadfoot earned more than 38.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,322 out of 7,022 | 39th |
Division Manufacturing | 1,463 out of 2,413 | 39th |
Major group Chemicals And Allied Products | 368 out of 673 | 45th |
Industry group Drugs | 255 out of 518 | 51st |
Industry Biological Products, Except Diagnostic Substances | 51 out of 112 | 55th |
Source: SEC filing on April 14, 2010.
News
aTYR PHARMA CEO Sanjay Shukla's 2023 pay falls 46% to $1.3M
April 5, 2024
aTYR PHARMA CEO Sanjay Shukla's 2021 pay jumps 75% to $1.9M
March 22, 2022
aTYR PHARMA CEO Sanjay Shukla's 2020 pay jumps 63% to $1.1M
March 23, 2021
aTYR PHARMA CEO Sanjay Shukla's 2019 pay falls 52% to $664K
April 2, 2020
aTYR PHARMA CEO Sanjay Shukla's 2018 pay falls 36% to $1.4M
March 28, 2019